Company intelligence / Profile preview

PharmAthene

Annapolis, Maryland, United States

Ownership: Private
Development stage: Phase 2

Overview

PharmAthene developed medical countermeasures for biological and chemical threats, including recombinant anthrax vaccines, bioscavengers for nerve agent exposure, and fully human monoclonal antibodies against anthrax. Its lead programs received significant U.S. government funding and some were on FDA fast track status. The company merged with Altimmune in 2017 to form a diversified immunotherapeutics firm targeting infectious diseases.[1][2][4][5][6]

Therapeutic areas: NeurologyInfectious Diseases
Modalities: Monoclonal antibodies (mAbs)Recombinant proteinsVaccines[2][5]
Industry: Biotech

Drug pipeline

5 assets

NasoVAX

Phase 2

Indications: Influenza

4 more assets in the full pipeline.

Request access →

Partnerships

Mederex Inc. (co-development partner for Valortim®)[1]U.S. Department of Defense / BARDA / NIAID – major government contracts/funding partners for product development [1][4]

Beyond the preview

Go deeper on PharmAthene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmAthene.

Explore the full profile